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Capsule 
   
Compared with control samples, women with endometriosis showed less intercellular adhesion 
molecule-1 expression by peritoneal macrophages and showed more inhibitory receptor 
expression by peripheral blood natural killer cells, favoring immune tolerance. 
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Abstract 
 
Objective: To investigate host immunologic response to endometriosis in terms of intercellular 
adhesion molecule (ICAM)-1 expression by macrophages and killer-cell inhibitory receptor 
(KIR) expression by natural killer (NK) cells. 
Design: Case control study of immunologic markers. 
Setting: University hospital. 
Patient(s): Twenty-eight Japanese women with endometriosis were studied. Control subjects 
were 26 women without endometriosis. Diagnoses were made at laparoscopy. 
Intervention(s): Venipuncture and laparoscopic peritoneal fluid collection. 
Main Outcome Measure(s): ICAM-1 expression by macrophages and KIR expression by NK 
cells, measured by flow cytometry. 
Result(s): In women with endometriosis, expression of ICAM-1 by peritoneal macrophages was 
significantly lower, and expression of KIR by NK cells in peritoneal fluid and peripheral blood 
was significantly higher, than in control subjects. 
Conclusion (s): Properties of macrophages and NK cells in women with endometriosis promote 
immune tolerance to implanted tissue in the peritoneal environment. Increased KIR+NK cells in 
peripheral blood may represent a risk factor for endometriosis. 
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Introduction 
  
 Endometriosis is a condition in which foci of hormonally responsive endometrial tissue 
including epithelial and stromal components are ectopically present in the peritoneal cavity and 
various organs. Though a reflux implantation theory by Sampson (1) and an epithelial metaplasia 
theory (2, 3) have been advocated, the pathogenesis of endometriosis has not been clearly 
understood. Recently, host immune responses have received increasing attention with respect to 
the pathogenesis and progression of endometriosis, considering that the ectopic endometrium in 
endometriosis proliferates and can show tumor like behavior (4, 5). As part of the immune 
response to endometriosis, immunocompetent cells (6-9) and cytokines (10-13) in peritoneal 
fluid (PF) have been analyzed. Cells in the PF are mainly mononuclear cells, particularly 
macrophages (90%); other mononuclear cells present include lymphocytes and natural killer 
(NK) cells. In women with endometriosis, numbers of macrophages are increased in PF (14, 15), 
and where increased macrophage-derived cytokines can also be found (10-13). These data 
indicate activation of macrophages in endometriosis. Simultaneously, functional depression of 
macrophages has also been reported in women with endometriosis (6, 16-18). At the same time, 
NK activity is decreased in mononuclear cells from peripheral blood (PB) and PF in women with 
endometriosis (19-21). Much remains to be understood concerning patients’ immune response in 
endometriosis from the viewpoint of cell activation. 
 ICAM-1, expressed on monocytes and macrophages, is important for signal trunsduction and 
antigen presentation to surrounding immunocompetent cells. This has led to ICAM-1 being 
recently considered to be an index for macrophage activation (22). NK cells can express 
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killer-cell inhibitory receptor (KIR) that recognize major histocompatibility antigen complex 
(MHC) class I on the target cells and signal inhibition of NK cytotoxicity. Recently, increased 
KIR expression by NK cells has been observed in women with endometriosis (23). 
 In the present study, we investigated whether there is any difference in the ICAM-1 expression 
rate by PF macrophages and also in the percentage of KIR expressing NK cells in PF and PB 
between women with and without endometriosis. 
 
 
Materials and Methods 
 
Subjects 
 Twenty-eight women with endometriosis (5 with stage I disease according to the revised 
classification of the American Fertility Society's classification of endometriosis (r-AFS); 6, stage 
II; 8, stage III; and 9, stage IV) were studied, as were 26 women without endometriosis (control 
group; 12 with benign ovarian cysts, 7 with uterine myoma, 4 with infertility, 2 with paraovarian 
cysts, and 1 with carcinoma in situ of uterine cervix). All patients were examined 
laparoscopically in the Department of Obstetrics and Gynecology of Kochi Medical School 
between April 1999 and August 2000. Mean ages for endometriosis and control groups were 32.8
±7.5 and 35.0±8.9, respectively  (no significant difference). Women with a history of 
pregnancy within 3 years or a history of treatment with gonadotropin-releasing hormone 
analogues within 3 years, as well as those with complications of apparent pelvic inflammatory 
disease, were excluded from analysis. Laparoscopy was performed during the early follicular 
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phase. Informed consent for obtaining PF samples during laparoscopy was obtained before the 
procedure. This study was approved by the institutional review board of Kochi Medical School 
Hospital.  
 Monoclonal antibodies (mAb) 
 Fluorescein isothiocyanate (FITC)-labeled anti-CD3 mAb and anti-CD4 mAb, as well as 
PE-labeled anti-CD8 mAb, were used to identify the T cell marker. Phycoerythrin (PE)-labeled 
anti-CD19 mAb was used as a B cell marker. FITC-labeled anti-CD16 mAb was used as an NK 
cell marker. FITC-labeled anti-CD14 mAb was used as a monocyte/macrophage marker (all from 
Beckman-Coulter). PE-labeled anti-CD54 (ICAM-1) mAb was used as a marker for 
monocyte/macrophage activation, and PE-labeled anti-CD158a, anti-CD158b, and CD94 were 
used as markers for killer-cell inhibitory receptor (KIR) (both from Beckman-Coulter). 
Peripheral blood mononuclear cells (PBMC) and peritoneal fluid mononuclear cells (PFMC) 
were allowed to react with the mAbs and were evaluated by flow cytometry to determine 
differences between women with and without endometriosis. 
Flow cytometry 
 PB (2 ml) was collected in heparinized Hank's buffer before laparoscopy. PF identified within 
the abdominal cavity was collected in heparinized Hank's buffer at laparoscopy. Each mAbs (5μ
l) was added to a 200μl aliquot of peripheral blood sample and allowed to react at room 
temperature for 1 hour. PF cells were suspended in phosphate-buffered saline (PBS) after 
pelleting by centrifugation at 1500 rpm for 7 minutes; then each mAb was added as for PB and 
allowed to react at room temperature for 1 hour. After the mAb reaction, erythrocytes were 
hemolyzed in ammonium chloride; then each cell sample was centrifuged and resuspended in 0.5 
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ml of PBS. An EPICS ELITE flow cytometer (Beckman-Coulter) was used for analysis. PBMC 
and PFMC fractions in each sample were gated with forward-scattered and laterally scattered 
light, and fluorescence intensities of cell populations in this region were measured. 
ICAM-1 
 The expression of CD14+ICAM-1 in monocytes in PBMC and expression in macrophages in 
PFMC were measured by flow cytometry. Anti-CD54 mAb was used for detection of ICAM-1. 
Mean fluorescence intensity for CD54 was measured. The mean CD54 fluorescence intensity in 
macrophages in PFMC was divided by that in monocytes in PBMC, as an index of ICAM-1 
activation potential (ICAM-1 intensity ratio; Fig. 1). 
KIR 
 The percentage of KIR+NK cells among all NK cells was measured in PBMC and PFMC by 
flow cytometry. Anti-CD158a mAb was used for detection of KIR2DL1 (KIR subfamily), and 
anti-CD158b mAb was used for detection of KIR2DL2 (KIR subfamily) (Fig. 2). 
 
 
Results 
 
 The absolute numbers of T cells, B cells, NK cells, and monocytes in peritoneal fluid were 
increased in women with endometriosis compared to controls. Simultaneous increase of 
peritoneal fluid was found in the peritoneal cavity, however, the concentration of each cell was 
not significantly increased compared to control (data not shown). Then proportions of each cell 
in PFMC were analyzed. These proportions did not differ significantly in PFMC nor in PBMC 
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between women with and without endometriosis (Table).  
 Fluorescence intensity of CD14+ICAM-1 expression in PB monocyte was not significantly 
different between women with and without endometriosis (p=0.08 by Kruskall-Wallis test). The 
ICAM-1 intensity ratio in samples from women with early endometriosis (stages I and II) was 
significantly lower than those from controls (2.9±1.1, 1.8±0.7, for controls and women with 
early endometriosis, respectively, p=0.03 by student T-test; Fig. 3). The ICAM-1 intensity ratio 
from women with advanced endometriosis (stages III and IV) was 2.6±1.3, not significantly 
different compared to controls (Fig. 3). 
 The percentage of KIR2DL1+NK cells among CD16+NK cells from PB in women with both 
early and advanced endometriosis were significantly higher than in controls (controls 11.7±5.5, 
early endometriosis 17.3 ± 8.3, and advanced endometriosis 17.5 ± 8.7, p=0.008 by 
Kruskall-Wallis test; Fig. 4). In women with advanced endometriosis, the percentage of 
KIR2DL1+NK cells among CD16+NK cells from PF was significantly higher than controls (11.6
±6.8, 24.3±15.6, for controls and women with advanced endometriosis, respectively, p=0.008 
by student T-test; Fig. 4). The percentage of KIR2DL1+NK cells among CD16+NK cells from PF 
from women with early endometriosis was 11.9±9.3, not significantly different compared to 
controls (p=0.70; Fig.4). There was no statistically significant difference in the percentage of 
KIR2DL2+NK cells from PB and PF among women with and without endometriosis (PB, p=0.20, 
PF, P=0.18 by Kruskall-Wallis test; Fig. 5). 
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Discussion 
  
 ICAM-1 is a transmembrane adhesion molecule present on macrophages that can bind to 
lymphocyte function-associated antigen (LFA)-1and Mac-1. ICAM-1, after induced by cytokines, 
plays an important role in the immune response by macrophages with surrounding T cells, NK 
cells, and macrophages that express LFA-1 and Mac-1 (7-9). Especially, in antigen presentation 
by macrophages, ICAM-1 is particularly important as a costimulatory molecule that functions 
together with the MHC and T cell receptor (7-9). Because of these immunologic functions, 
ICAM-1 is considered to be an index for macrophage activation (22). 
 To examine the individual activation potential of macrophages that had migrated into the 
peritoneal cavity from peripheral blood, ICAM-1 fluorescence intensity of macrophages from PF 
was divided by that in monocytes in PBMC (ICAM-1 intensity ratio). Decreased ICAM-1 
intensity ratio in women with early endometriosis indicates relative inactivation of macrophages 
in the peritoneal cavity and may predict a decreased immune response against foreign body 
(ectopic endometrial tissue) in that site. Increased ICAM-1 intensity ratio in advanced 
endometriosis, but no significantly different compared to controls, is possibly as a result of 
repeated episodes of inflammation. 
 KIR2DL1 and KIR2DL2 (both KIR subfamilies) belong to the immunoglobulin superfamily 
and function as receptors expressed on the surface of NK cells and part of T cells. Upon 
recognizing the different C-locus of HLA class I of the target cell, both KIR inhibit NK cell 
activation signaled from CD16, CD2, and LFA-1 (24). In this study, the percentage of 
KIR2DL1+NK among CD16+NK cells in PB was significantly increased in both early and 
advanced endometriosis, while that of KIR2DL2+NK cells was not. Furthermore, the percentage 
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of KIR2DL1+NK among CD16+NK cells in PF was significantly increased in advanced 
endometriosis. Because increased percentage of KIR2DL1+NK among CD16+NK cells in PB 
was observed even in early stage endometriosis, and NK cells were over 1000 times more 
abundant among PB than PF, increased KIR2DL1+NK cells among PBMC probably should not 
be affected by intraperitoneal condition. Instead, originally increased KIR2DL1+NK cells in PB 
more likely migrate into the peritoneal cavity in advanced endometriosis. 
 This study did not clarify a correlation between the percentage of KIR+NK cells and NK 
activity. Decreased NK activity in PBMC has been reported in women with endometriosis (19, 
20, 25). Furthermore, NK activity reportedly failed to recover after LASER cauterization of 
endometriotic lesions (26). This observation suggests that decreased NK activity may be a 
pathogenic factor in endometriosis rather than a result. Another epidemiologic observation of 
frequent familial occurrence of endometriosis (27-29) indicates that genetic factor are involved 
in pathogenesis. Demonstration of increased KIR2DL1+NK cells in peripheral blood may be 
related to these epidemiologic findings. 
 The immunologic properties that we observed--decreased ICAM-1 expression by macrophages 
in PF, and increased KIR+NK cells in PF and particularly in PB--suggest relative immune 
tolerance in women with endometriosis. Further examination of other function molecule 
expression and cytokine production by peritoneal macrophages, and further examination of a 
correlation between the percentage of KIR expressing NK cells and NK cytotoxicities against 
endometriotic cells are needed for understanding the pathogenesis of endometriosis. 
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Legends 
 
Fig. 1.  
 Calculation of the fluorescence intensity ratio for intercellular adhesion molecule (ICAM)-1 by 
flow cytometry in women with endometriosis. The Y-axis shows fluorescence intensity of CD14 
expressing cells. The X-axis shows fluorescence intensity of ICAM-1 (CD54) expressing cells. 
 The term a indicates mean fluorescence intensity corresponding to ICAM-1 expression by 
CD14+ICAM-1+ monocytes in peripheral blood. The term b indicates mean fluorescence 
intensity representing ICAM-1 expression by CD14+ICAM-1+ macrophages in peritoneal fluid. 
 
Fig. 2.  
 Two-color flow cytometric scattered plots for detection of killer-cell inhibitory receptor (KIR) 
2DL1+ natural killer (NK) cells (A) and KIR2DL2+NK cells (B) in women with endometriosis. 
 Scattered plots show mononuclear cells in peripheral blood, and peritoneal fluid. FITC- labeled 
anti-CD16 monoclonal antibody (mAb), PE-labeled anti-KIR2DL1 (CD158a) mAb (A) and 
PE-labeled anti-KIR2DL2 (CD158b) mAb (B) were used respectively. A: zone 1+ zone 2 
includes CD16+NK cells; zone 2 includes KIR2DL1+NK cells. KIR2DL1+NK among CD16+NK 
cells = zone 2 / (zone 1 + zone 2). The same analysis was performed for KIR2DL2+NK cells. 
 
Fig. 3. 
 ICAM-1 intensity ratios calculated by fluorescence intensity of ICAM-1 expression of PB 
monocytes and PF macrophage in women without and with early and advanced endometriosis. 
The ICAM-1 intensity ratio in samples from women with early endometriosis was significant 
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(p=0.03 by student T-test). The ICAM-1 intensity ratio from women with advanced 
endometriosis was not significant (p=0.51 by student T-test). 
 
Fig. 4. 
 The percentage of KIR2DL1+NK cells among CD16+NK cells from peripheral (PB) and 
peritoneal fluid (PF) in women without and with early and advanced endometriosis. Data shows 
individual values and mean (-) of each column. The percentage of KIR2DL1+NK cells from PB 
between controls and women with both early and advanced endometriosis were statistically 
significant (p=0.008 by Kruskall-Wallis test). The percentage of KIR2DL1+NK cells from PF 
from women with early endometriosis was not significantly different compared to controls 
(p=0.70 by student T-test). In women with advanced endometriosis, the percentage of 
KIR2DL1+NK cells from PF was statistically significant (p=0.008 by student T-test).  
 
Fig. 5. 
 The percentage of KIR2DL2+NK cells among CD16+NK cells from peripheral (PB) and 
peritoneal fluid (PF) in women without and with early and advanced endometriosis. Data shows 
individual values and mean (-) of each column. There was no statistically significant difference 
in the percentage of KIR2DL2+NK cells from PB and PF among women with and without 
endometriosis (PB, p=0.20, PF, P=0.18 by Kruskall-Wallis test). 
 
 
